Genetics in coeliac disease
- PMID: 15925839
- DOI: 10.1016/j.bpg.2005.01.001
Genetics in coeliac disease
Abstract
Coeliac disease has a strong genetic component, higher than for many other common complex diseases. Possession of the HLA-DQ2 variant is required for presentation of disease causing dietary antigens to T cells, although this is also common in the healthy population. Non-HLA genetic factors account for the majority of heritable risk. Linkage studies have identified promising regions on chromosomes 5 and 19, with multiple other loci awaiting definitive confirmation in independent studies. Inherited variants in the tightly clustered chromosome 2q CD28-CTLA4-ICOS region are associated with disease, although of weak effect size. Larger sample sizes are necessary in coeliac disease genetic studies to detect small effects, alternatively meta-analysis offers promise. Newer methods including gene expression analysis and genome wide association studies will advance understanding of genetic susceptibility. Identification of coeliac disease genes may improve diagnostic/prognostic markers, basic understanding of disease aetiology, permit development of novel therapeutics and provide insight into other autoimmune disorders.
Similar articles
-
A combined genetics and genomics approach to unravelling molecular pathways in coeliac disease.Novartis Found Symp. 2005;267:113-34; discussion 134-44. Novartis Found Symp. 2005. PMID: 15999804
-
Haplotypes in the CTLA4 region are associated with coeliac disease in the Irish population.Genes Immun. 2006 Jan;7(1):19-26. doi: 10.1038/sj.gene.6364265. Genes Immun. 2006. PMID: 16237465
-
Genetic analysis of the CD28/CTLA4/ICOS (CELIAC3) region in coeliac disease.Tissue Antigens. 2004 Nov;64(5):593-9. doi: 10.1111/j.1399-0039.2004.00312.x. Tissue Antigens. 2004. PMID: 15496203
-
A genetic perspective on coeliac disease.Trends Mol Med. 2010 Nov;16(11):537-50. doi: 10.1016/j.molmed.2010.09.003. Epub 2010 Oct 12. Trends Mol Med. 2010. PMID: 20947431 Review.
-
Genetic background of celiac disease and its clinical implications.Am J Gastroenterol. 2008 Jan;103(1):190-5. doi: 10.1111/j.1572-0241.2007.01471.x. Am J Gastroenterol. 2008. PMID: 18184122 Review.
Cited by
-
Interactions within the MHC contribute to the genetic architecture of celiac disease.PLoS One. 2017 Mar 10;12(3):e0172826. doi: 10.1371/journal.pone.0172826. eCollection 2017. PLoS One. 2017. PMID: 28282431 Free PMC article.
-
Celiac disease: prevalence, diagnosis, pathogenesis and treatment.World J Gastroenterol. 2012 Nov 14;18(42):6036-59. doi: 10.3748/wjg.v18.i42.6036. World J Gastroenterol. 2012. PMID: 23155333 Free PMC article. Review.
-
The measurement and clinical significance of intestinal permeability.Curr Gastroenterol Rep. 2008 Oct;10(5):443-9. doi: 10.1007/s11894-008-0083-y. Curr Gastroenterol Rep. 2008. PMID: 18799118 Review.
-
Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease.Nat Genet. 2011 Nov 6;43(12):1193-201. doi: 10.1038/ng.998. Nat Genet. 2011. PMID: 22057235 Free PMC article.
-
HLA and celiac disease susceptibility: new genetic factors bring open questions about the HLA influence and gene-dosage effects.PLoS One. 2012;7(10):e48403. doi: 10.1371/journal.pone.0048403. Epub 2012 Oct 31. PLoS One. 2012. PMID: 23119005 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials